StockWatch: Pfizer Under Pressure with Omicron!
A research team has found that the Pfizer vaccine has 40 times fewer antibodies available for fighting the omicron variant.
The Omicron variant has now been detected in 19 US states, and nearly 50 countries worldwide.
With the top pharmaceutical companies on red alert with this new strain, just how will stocks be affected as we head into 2022?
Timestamps:
- PFE 02:00
- MRNA 03:50